<?xml version="1.0" encoding="UTF-8"?>

<wo-patent-document lang="fr" status="175" country="OA">
  <wo-bibliographic-data status="BR100 Migrated">
    <classifications-ipcr>
      <classification-ipcr sequence="0001">
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>45</main-group>
        <subgroup>06</subgroup>
        <classification-value>A</classification-value>
      </classification-ipcr>
      <classification-ipcr sequence="0002">
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>9</main-group>
        <subgroup>00</subgroup>
        <classification-value>A</classification-value>
      </classification-ipcr>
    </classifications-ipcr>
    <application-reference>
      <document-id>
        <country>OA</country>
        <doc-number>1/2007/000373</doc-number>
        <date>20060313</date>
      </document-id>
    </application-reference>
    <priority-claims>
      <priority-claim sequence="0001" kind="national">
        <country>US</country>
        <doc-number>11/093,742</doc-number>
        <date>20050330</date>
      </priority-claim>
    </priority-claims>
    <parties>
      <applicants>
        <applicant sequence="0001" app-type="applicant" designation="all">
          <addressbook lang="fr">
            <name>ANDRX LABS, LLC</name>
            <address>
              <address-1>4955 Orange Dr., DAVIE, Florida 33314</address-1>
              <country>US</country>
            </address>
          </addressbook>
          <nationality>
            <country/>
          </nationality>
          <residence>
            <country>US</country>
          </residence>
        </applicant>
        <applicant sequence="0002" app-type="applicant" designation="all">
          <addressbook lang="fr">
            <name>TAKEDA PHARMACEUTICAL COMPANY, LIMITED</name>
            <address>
              <address-1>1-1, Doshomachi 4-chome, Chuo-ku Osaka-shi</address-1>
              <country>JP</country>
            </address>
          </addressbook>
          <nationality>
            <country/>
          </nationality>
          <residence>
            <country>JP</country>
          </residence>
        </applicant>
      </applicants>
      <inventors>
        <inventor sequence="0001">
          <addressbook lang="fr">
            <name>CARDINAL, Jack, R.</name>
            <address>
              <address-1>8604 Northwest 77th Street</address-1>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="0002">
          <addressbook lang="fr">
            <name>LODIN, Unchalee</name>
            <address>
              <address-1>19943 Northeast 19th Place North</address-1>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="0003">
          <addressbook lang="fr">
            <name>NANGIA, Avinash</name>
            <address>
              <address-1>701 George Washington Hwy.</address-1>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="0004">
          <addressbook lang="fr">
            <name>OKOCHI, Kazuhiro</name>
            <address>
              <address-1>c/o Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-chome, Yodogawa-ku, Osaka-shi</address-1>
              <country>JP</country>
            </address>
          </addressbook>
        </inventor>
      </inventors>
      <agents>
        <agent sequence="0001" rep-type="agent">
          <addressbook lang="fr">
            <name>FORCHAK IP &amp; LEGAL ADVISORY</name>
            <address>
              <address-1>3rd Floor, Viccul Building, Apt. 15-16, Carr Street, Behind Police Barracks, New Town</address-1>
              <country>CM</country>
            </address>
          </addressbook>
        </agent>
      </agents>
    </parties>
    <invention-title lang="fr">Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative.</invention-title>
    <wo-term-of-grant>
      <date>20140131</date>
      <doc-number>016217</doc-number>
    </wo-term-of-grant>
    <wo-date-of-expiry>20260313</wo-date-of-expiry>
    <pct-or-regional-filing-data>
      <document-id>
        <country>US</country>
        <doc-number>PCT/US06/009082</doc-number>
        <date>20060313</date>
      </document-id>
    </pct-or-regional-filing-data>
    <pct-or-regional-publishing-data>
      <document-id>
        <country>IB</country>
        <doc-number>WO/2006/107528</doc-number>
        <date>20061012</date>
      </document-id>
    </pct-or-regional-publishing-data>
    <wo-national-office-event national-office-event-type="Filed" doc-number="OA/1/2007/000373" event-name="Filing">
      <wo-national-office-event-date>
        <date>20060313</date>
      </wo-national-office-event-date>
    </wo-national-office-event>
    <wo-national-office-event national-office-event-type="175" event-name="-">
      <wo-national-office-event-date>
        <date>20070928</date>
      </wo-national-office-event-date>
    </wo-national-office-event>
    <wo-national-office-event national-office-event-type="Registered" doc-number="016217" event-name="Registration">
      <wo-national-office-event-date>
        <date>20140131</date>
      </wo-national-office-event-date>
    </wo-national-office-event>
    <wo-national-office-filing-data appl-type="BR Brevet" file-type="1">
      <kind-of-protection>BR Brevet PCT</kind-of-protection>
    </wo-national-office-filing-data>
  </wo-bibliographic-data>
  <abstract lang="fr">
    <p num="0001">A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.</p>
  </abstract>
</wo-patent-document>
